Ads
related to: apremilast patient information leaflet- Support
Find Resources To Help You
Get Started With Treatment.
- SKYRIZI® Resources
Skyrizi® Complete Offers Resources
To Stay On Track With Treatment.
- SKYRIZI® Dosing Info
Learn About The Dosing Frequency Of
SKYRIZI®. See Results For SKYRIZI®.
- Find a Doctor
Find A Doctor Near You
And Ask About SKYRIZI®.
- Hear Patient Testimonials
Watch Real Patient Stories
On Our Site Today.
- Register For More Info
Be The First To Know About
SKYRIZI® Info. Sign Up Now.
- Support
Search results
Results From The WOW.Com Content Network
Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. [4] The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4). [ 4 ]
In the European Union, the European Medicines Agency has jurisdiction and the relevant documents are called the "summary of product characteristics" (SPC or SmPC) and the document for end-users is called the "patient information leaflet" or "package leaflet". The SPC is not intended to give general advice about treatment of a condition but does ...
Celgene has good news -- and it has bad news. The company announced phase 3 results for apremilast in treating psoriasis at the American Academy of Dermatology meeting this weekend in Miami.
Thalidomide, sold under the brand names Contergan and Thalomid among others, is an oral medication used to treat a number of cancers (e.g., multiple myeloma), graft-versus-host disease, and many skin disorders (e.g., complications of leprosy such as skin lesions).
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Ads
related to: apremilast patient information leaflet